Pune, India -- (SBWIRE) -- 05/28/2019 -- The Global Nebulizer Market is estimated to grow at CAGR above 6.2 % over the forecast time frame 2019-2026 and reach the market value around USD 1.4 billion by 2026.

Nebulizers are devices for the delivery of respiratory drugs which transform liquid drugs into aerosols (gas fluid parts). The medication is transformed into a brum that can be delivered directly to the lungs of the patient. Among the key factors driving the use of nebulizers are increased incidence of chronic respiratory diseases and rapid technologic progress. The growth is driven primarily by the rising incidence of chronic respiratory conditions, increasing home healthcare demand and increasing geriatric populations.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1386

In recent years, home health equipment has become more and more popular. The use of home health care products is being encouraged through the miniaturization of products and technological developments. The growing geriatric population, high chronic diseases incidence and healthcare expenditure need to be reduced are also expected to be some of the high-impact nebulizer rendering factors. Healthcare at home is an affordable alternative to costly hospitalization that is expected to boost the market for nebulizing. Facilities in domestic healthcare are enhanced through easy access to compact nebulizers that are ideal for homes and technological innovations to reduce sound and improve their functions.

The growing geriatric population worldwide is expected to increase breathing aid use during the forecast period. The global elderly people are forecast to rise from 841.0 million by 2014 to about 2.0 billion by 2050, according to the World Health Organization (WHO). For example, Elderly persons are susceptible to respiratory conditions such as COPD and sleep apnea, which are expected to propel the growth of the nebulizer market in the growth of the geriatric population.

Regional Stance

North America was the biggest share of the market in 2018 and, because of an increase in chronic respiratory diseases, it is estimated to be experiencing significant increases over the forecast period. In 2014, COPD was estimated as the third largest cause of death, according to the Centers for Disease Control and Prevention (CDC). In addition, an increase in the North American geriatric population leads to a growing number of respiratory and surgical disorders that can also promote regional growth.

Due to the increasing geriatric and respiratory diseases population, the Asia Pacific region is expected to show a CAGR of the fastest overall during the forecast period. According to the Japanese Ministry of Health, Labor and Welfare, COPD is the seventh most common cause of death in Japan. Moreover, in Japan, COPD cases increased by 24.2 percent between 2005 and 2016, according to the Institute for Health Metrics and Evaluation. Moreover, the pulmonary disease has been estimated to cause a significant proportion of the population in countries like India and China.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/nebulizer-market

Key Findings

The pneumatic nebulizer sector was the market leader in 2018 in terms of revenues.

The demand is expected to increase factors such as the high prevalence of breathing disorders in the aging population.

The segment of the mesh nebulizer is expected to grow rapidly during the forecast period.

The growth of the segment in the projected period is expected to increase in geriatric population around the globe and the preference for home health care.

The growth of Asian Pacific over the forecast period is expected to be the fastest due to the increase in hospitals and clinics and increased health care expenditure.

Key Players & Strategies

Koninklijke Philips N.V.; Omron Corporation; PARI Pharma; and Allied Healthcare Products, Inc. are prominent key players. Key players participate in the adoption of various strategies for strengthening their market position such as fusions and acquisitions, product launches and partnerships.

In June 2016, two SUN-101 pivotal Phase III trials were conducted with PARI Pharma eFlow technology. Sunovion aims to combine inhaler and nebulizer attributes into a single system, together with SUN-101 and eFlow technology.

Browse all official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Nebulizer
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Nebulizer Market By Type
1.2.2.1. Global Nebulizer Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.2.2. Global Nebulizer Market Revenue Share By Type in 2017
1.2.2.3. Mesh
1.2.2.4. Pneumatic
1.2.2.4.1. Portable
1.2.2.4.2. Standalone
1.2.2.5. Ultrasonic
1.2.2.5.1. Portable
1.2.2.5.2. Standalone
1.2.3. Nebulizer Market by Geography
1.2.3.1. Global Nebulizer Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.3.2. North America Nebulizer Market Revenue and Growth Rate (2015-2026)
1.2.3.3. Europe Nebulizer Market Revenue and Growth Rate (2015-2026)
1.2.3.4. Asia-Pacific Nebulizer Market Revenue and Growth Rate (2015-2026)
1.2.3.5. Latin America Nebulizer Market Revenue and Growth Rate (2015-2026)
1.2.3.6. Middle East and Africa (MEA) Nebulizer Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Nebulizer Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Nebulizer Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global Nebulizer Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Nebulizer Major Manufacturers in 2017

CHAPTER 4. Nebulizer MARKET BY TYPE

4.1. Global Nebulizer Revenue By Type
4.2. Mesh
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Pneumatic
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3.3. Portable
4.3.4. Standalone
4.4. Ultrasonic
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4.3. Portable
4.4.4. Standalone

CHAPTER 5. NORTH AMERICA Nebulizer MARKET BY COUNTRY

5.1. North America Nebulizer Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2. North America Nebulizer Market Revenue Share Comparison, 2015 & 2026 (%)
5.3. U.S.
5.3.1. U.S. Nebulizer Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
5.4. Canada
5.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
5.5. Mexico
5.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 6. EUROPE Nebulizer MARKET BY COUNTRY

6.1. Europe Nebulizer Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. Europe Nebulizer Market Revenue Share Comparison, 2015 & 2026 (%)
6.3. UK
6.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.4. Germany
6.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.5. France
6.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.6. Spain
6.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
6.7. Rest of Europe
6.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 7. ASIA-PACIFIC Nebulizer MARKET BY COUNTRY

7.1. Asia-Pacific Nebulizer Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Asia-Pacific Nebulizer Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. China
7.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4. Japan
7.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5. India
7.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.6. Australia
7.6.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.7. South Korea
7.7.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.8. Rest of Asia-Pacific
7.8.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 8. LATIN AMERICA Nebulizer MARKET BY COUNTRY

8.1. Latin America Nebulizer Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Latin America Nebulizer Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. Brazil
8.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4. Argentina
8.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5. Rest of Latin America
8.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 9. MIDDLE EAST Nebulizer MARKET BY COUNTRY

9.1. Middle East Nebulizer Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Middle East Nebulizer Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. Saudi Arabia
9.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4. UAE
9.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5. Rest of Middle East
9.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 10. AFRICA Nebulizer MARKET BY COUNTRY

10.1. Africa Nebulizer Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Africa Nebulizer Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. South Africa
10.3.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4. Egypt
10.4.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5. Rest of Africa
10.5.1. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)

CHAPTER 11. COMPANY PROFILE

11.1. Koninklijke Philips N.V.
11.1.1. Company Snapshot
11.1.2. Overview
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. Key Developments
11.1.6. Strategies
11.2. Omron Corporation
11.2.1. Company Snapshot
11.2.2. Overview
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. Key Developments
11.2.6. Strategies
11.3. PARI Pharma
11.3.1. Company Snapshot
11.3.2. Overview
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. Key Developments
11.3.6. Strategies
11.4. Allied Healthcare Products, Inc.
11.4.1. Company Snapshot
11.4.2. Overview
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. Key Developments
11.4.6. Strategies
11.5. Others
11.5.1. Company Snapshot
11.5.2. Overview
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. Key Developments
11.5.6. Strategies

CHAPTER 12. RESEARCH APPROACH

12.1. Research Methodology
12.1.1. Initial Data Search
12.1.2. Secondary Research
12.1.3. Primary Research
12.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1386

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this Premium Research Report - https://www.acumenresearchandconsulting.com/buy-now/0/1386

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.